[Treatment of motor urge incontinence with the beta 2-sympathomimetic drug clenbuterol (author's transl)].
15 female patients with motor urge incontinence were treated with Clenbuterol (30--40 micrograms daily, orally) for 4--6 weeks. Urodynamic controls showed the reduction or suppression of detrusor contractions. Bladder capacity increased. We found no change in the maximum urethral closure pressure due to the medication. Side effects were few.
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D002976:Clenbuterol / Q000627:therapeutic use*; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D014549:Urinary Incontinence / Q000188:drug therapy*
D000318:Adrenergic beta-Agonists; D004983:Ethanolamines; D002976:Clenbuterol
Die Therapie der motorischen Reizblase mit dem beta 2-Sympathomimetikum Clenbuterol.